{"id":2832,"date":"2025-02-06T14:22:23","date_gmt":"2025-02-06T11:22:23","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2832"},"modified":"2025-11-03T20:24:39","modified_gmt":"2025-11-03T17:24:39","slug":"percheron-therapeutics-announces-terminated-of-atl1102-study-for-dmd","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/fr\/percheron-therapeutics-announces-terminated-of-atl1102-study-for-dmd\/","title":{"rendered":"Percheron Therapeutics annonce la fin de l&#039;\u00e9tude ATL1102 sur la DMD"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u201cOne way or other, we don\u2019t think ATL-1102 can remain the centerpiece of the story put forward to investors,\u201d Garner told investors in a webinar this morning.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In summary, the trial failed to detect any meaningful difference between the boys actively treated with ATL-1102, compared with the placebo cohort. [Read More: <a href=\"https:\/\/dmdwarrior.com\/percheron-disappointed-in-avicursen-atl1102-study-for-duchenne-dmd\/\">Percheron Disappointed in Avicursen (ATL1102) Study For Duchenne (DMD)<\/a>]<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<div class=\"youtube-embed\" data-video_id=\"mSEmhOawVlc\"><iframe title=\"Webinar Recording \u2013 Phase IIb results discussion.\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/mSEmhOawVlc?feature=oembed&#038;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Read More<\/strong>:\u00a0<a href=\"https:\/\/dmdwarrior.com\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Clinical Trials for Duchenne (List of All Researches)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cOne way or other, we don\u2019t think ATL-1102 can remain the centerpiece of the story put forward to investors,\u201d Garner told investors in a webinar this morning. In summary, the trial failed to detect any meaningful difference between the boys actively treated with ATL-1102, compared with the placebo cohort. [Read More: Percheron Disappointed in Avicursen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2835,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[114,113,112,115],"class_list":["post-2832","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-atl1102","tag-avicursen","tag-percheron","tag-percheron-therapeutics"],"subtitle":"Percheron Therapeutics annonce l'abandon de son principal candidat m\u00e9dicament, suite \u00e0 l'\u00e9chec de l'essai clinique sur la dystrophie musculaire de Duchenne en d\u00e9cembre. Percheron Therapeutics annonce la fin de l'\u00e9tude ATL1102 sur la DMD.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=2832"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2832\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/2835"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=2832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=2832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=2832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}